Extracted from this filing and checked against the source text.
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
VSEE HEALTH, INC. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).
- Exchange
- nasdaq
- Notice
- noncompliance notice
- Deficiency
- stockholders equity
- Rules
- 5550(b)(1)
Exact text from the filing
September 2, 2025, the Company received an additional notification letter (the “Letter”) from the Staff indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Equity Rule”) because the Company’s stockholders’ equity had fallen below the $2,500,000 required minimum for continued listing. The Company’s stockholders’ deficit was $18,488 as of December 31, 2024, as reported in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 . The Letter also noted that, as of August 29, 2025, the Company did not meet the alternatives of marke
View on SEC.gov
Listing & Compliance Notices
SEC 8-K Item 3.01
confidence 0.95
VSEE HEALTH, INC. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).
- Exchange
- nasdaq
- Notice
- delisting notice
- Deficiency
- late filing
- Rules
- 5250(c)(1)
Exact text from the filing
August 28, 2025 (although as of the filing of this Current Report on Form 8-K, trading has not been suspended) . The Company filed an appeal with the Nasdaq Hearings Panel (the “Panel”), and a hearing before the Panel is scheduled to be held on September 9, 2025. The Staff’s determination to deny the Company’s request to continue listing on Nasdaq was based on the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company’s failure to timely file with the Securities and Exchange Commission (the “SEC”) its Annual Report on Form 10-K for the fiscal year ended Decembe
View on SEC.gov